Scarica l'app Stockscreener
3.22
7.74%
-0.27
Dopo l'orario di chiusura:
3.25
0.03
+0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$3.49
Aprire:
$3.47
Volume 24 ore:
3.64M
Relative Volume:
0.60
Capitalizzazione di mercato:
$718.93M
Reddito:
-
Utile/perdita netta:
$-283.26M
Rapporto P/E:
-2.1905
EPS:
-1.47
Flusso di cassa netto:
$-273.61M
1 W Prestazione:
-4.73%
1M Prestazione:
+97.55%
6M Prestazione:
-47.13%
1 anno Prestazione:
-41.35%
Intervallo 1D:
$3.21
$3.65
Intervallo di 1 settimana:
$3.12
$3.65
Portata 52W:
$1.52
$12.00
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.22 | 718.93M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
| 2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-05 | Iniziato | Citigroup | Buy |
| 2023-08-14 | Iniziato | TD Cowen | Market Perform |
| 2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
| 2021-03-01 | Iniziato | BofA Securities | Buy |
| 2021-03-01 | Iniziato | Goldman | Neutral |
| 2021-03-01 | Iniziato | JP Morgan | Neutral |
| 2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.2%What's Next? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Up 8.8%Time to Buy? - MarketBeat
Vanguard Group Inc. Reduces Stake in Sana Biotechnology Inc. - GuruFocus.com
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable
Sana Biotechnology, Inc. (SANA): A Bull Case Theory - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Shares Up 13.9%Time to Buy? - MarketBeat
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Quantisnow
Sana Biotech extends rally as Morgan Stanley cites platform's potential - MSN
Vir, Sana gain new modality POC: BioCentury’s Clinical Report - BioCentury
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.5%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading 13.9% HigherHere's Why - MarketBeat
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? - MSN
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
JPMorgan Chase & Co. Cuts Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana stock rallies 280% on pancreatic cell transplant study - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Gap DownShould You Sell? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Down 5.5%Here's Why - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward - STAT
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.5%Here's What Happened - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 5.7%Here's Why - MarketBeat
Sana Biotechnology price target raised to $12 from $9 at Morgan Stanley - MSN
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Up 5.7%Time to Buy? - MarketBeat
This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025. - MSN
Sana Biotechnology Shows Promise with Hypoimmune Platform - TipRanks
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Barclays PLC - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Shares Gap Up – Here’s What Happened - Defense World
Sana Biotechnology (NASDAQ:SANA) Price Target Raised to $11.00 - Defense World
FMR LLC sells $1.89 million in Sana Biotechnology shares By Investing.com - Investing.com South Africa
SANA Stock Surges 152% In A Week On Upbeat Initial Diabetes Study Data - Barchart
FMR LLC Reduces Holdings in Sana Biotechnology Inc - GuruFocus.com
Insider Selling: Sana Biotechnology, Inc. (NASDAQ:SANA) Insider Sells 290,912 Shares of Stock - MarketBeat
FMR LLC sells $1.89 million in Sana Biotechnology shares - Investing.com India
Sana Biotechnology (NASDAQ:SANA) Shares Gap UpHere's What Happened - MarketBeat
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future - Mugglehead
Shares of Sana soar following breakthrough in diabetes therapy trials - Kursiv Media
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In Excitement - NewsBreak
Cowen Pounds the Table on Sana Biotechnology Stock - TipRanks
This Biotech Stock Just Soared 240%. Why It Can Go Higher. - MSN
First data for immune-evading type 1 diabetes therapy trigger Sana stock surge - FirstWord Pharma
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type - openPR
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance - BioWorld Online
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):